Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
about
The risk associated with indwelling catheters in children with haemophilia.Barriers to primary prophylaxis in haemophilic children: the issue of the venous access.Central venous access devices in haemophilia.Consensus recommendations for use of central venous access devices in haemophilia.Central venous access devices in patients with hemophilia.Immune tolerance: critical issues of factor dose, purity and treatment complications.International workshop on immune tolerance induction: consensus recommendations.Optimizing outcomes for patients with severe haemophilia A.Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis.Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.Novel drugs to treat hemophilia.Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia.Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.How to manage invasive procedures in children with haemophilia.Central venous access device-related infections in patients with haemophilia.Prevention of bleeding in hemophilia patients with high-titer inhibitors.Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors.Emergency department visits in children with hemophilia.Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.Fatal central venous catheter-related infection in haemophilia.Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.How I treat inhibitors in haemophilia.Prolonged effect of a new O-glycoPEGylated FVIII (N8-GP) in a murine saphenous vein bleeding model.
P2860
Q34660967-70F98244-87A8-41C4-8F7F-B066FF7891CAQ34910120-D884C991-9320-4753-8D8A-763D161FE2F3Q35666735-5D8EB679-638A-4A1A-A80C-E58CF63705F6Q35882783-3FCB107B-CFCB-499F-B73A-E9D48E5A7DA3Q36315174-7657DFF1-873E-4385-A23F-59BC9DE41F02Q36661848-91F00EB3-23C6-44E4-A1CC-9FF0C3258828Q36861097-61159866-678C-4FF3-82CE-0DCEFC40A3CDQ36932769-6AFC73EA-BC3E-4D9B-8E37-717A2ABE6C51Q37001590-F5B4BD32-E3A1-43A5-AEE8-DBC77E2BE36EQ37052161-5475806F-005F-4B39-9724-5EF1642495EEQ37775029-C87A930A-BDCD-4238-87CD-D2B2E0A5CB15Q37845930-29C9605A-16C5-4982-A952-0455B04E9B5CQ37984127-BD67CFEC-7040-4824-AB4C-45C51E572B47Q37990524-19C91015-5A66-4086-A977-103600975432Q38084355-733FDE18-FDBB-4F9E-A18A-9EC94F0AF79CQ38456352-A18BAD85-D14D-4ACD-BD0C-583D9E0E2637Q41143756-835C683A-EB44-42DA-AD6C-F0DC21430132Q41363389-8C10408B-97F7-4377-9A25-A69258C7893BQ44211358-814313D4-A571-4641-B78D-59FA3C2D0080Q44618534-ED3F311F-CD09-4A5A-A79F-C5CC9A90F6AAQ45157141-715887DD-74DD-4E78-A400-90C130361CF0Q45856110-17F632EC-D107-434A-A45D-AE80215EB09CQ45859168-A8AF7153-D70A-45FE-900F-0520A2B5A8EAQ45879927-0DDBDCC1-985E-4EC9-B3AC-75EFDBB467B9Q45887979-A68B97A2-321A-48C4-9323-669298DA2158
P2860
Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Surveillance of infectious com ...... in children with haemophilia.
@en
Surveillance of infectious com ...... in children with haemophilia.
@nl
type
label
Surveillance of infectious com ...... in children with haemophilia.
@en
Surveillance of infectious com ...... in children with haemophilia.
@nl
prefLabel
Surveillance of infectious com ...... in children with haemophilia.
@en
Surveillance of infectious com ...... in children with haemophilia.
@nl
P2093
P2860
P1433
P1476
Surveillance of infectious com ...... in children with haemophilia.
@en
P2093
Donfield SM
Hunsberger S
Shapiro AD
Tarantino MD
P2860
P304
P356
10.1046/J.1365-2516.2003.00793.X
P577
2003-09-01T00:00:00Z